10-Q · January 29, 2025
Hawkins reported Q3 sales of $226.205M (up $17.709M or +8.5% YoY) with gross profit of $48.424M and diluted EPS of $0.72. Water Treatment was the driver, growing to $99.752M while Industrial declined slightly to…
Earnings analysis · 10-K
Filed May 13, 2026 · Our reading of the company's report
The latest report
Hawkins, Inc. reported solid growth in fiscal 2026 with total sales of $1,083.7 million, marking an 11% increase from the previous year, driven primarily by the Water Treatment segment which saw a 22% growth. Despite…
Hawkins, Inc. reported solid growth in fiscal 2026 with total sales of $1,083.7 million, marking an 11% increase from the previous year, driven primarily by the Water Treatment segment which saw a 22% growth. Despite increased sales, diluted EPS decreased slightly to $3.91 due to rising costs, particularly in materials and interest expenses, reflecting the company's ongoing efforts to navigate a competitive environment while pursuing strategic acquisitions to enhance its product portfolio and market reach.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Total sales reached $1,083.7 million in fiscal 2026, an increase of 11% from $974.4 million in fiscal 2025.
Sales in the Water Treatment segment increased by 22%, contributing $543.3 million to overall sales.
Operating cash flow rose by 30% to $144.3 million, up from $111.1 million in fiscal 2025.
Acquisitions contributed approximately $83.3 million to sales in the Water Treatment segment.
Gross profit increased by 9% to $245.1 million, maintaining a gross margin of 22.6%.
The company declared cash dividends totaling $15.7 million in fiscal 2026, up from $14.6 million in 2025.
Interest expense surged to $13.5 million in fiscal 2026, up from $5.4 million in fiscal 2025, due to higher debt from acquisitions.
The Food and Health Sciences segment faced a slight sales decline amid competitive pricing pressures, decreasing 1% to $320.7 million.
Fluctuations in raw material costs remain a risk, impacting gross margins amid rising expenses.
Guidance for fiscal 2027 emphasizes continued revenue growth, capitalizing on recent acquisitions and improving operational efficiency.
Hawkins reported Q3 sales of $226.205M (up $17.709M or +8.5% YoY) with gross profit of $48.424M and diluted EPS of $0.72. Water Treatment was the driver, growing to $99.752M while Industrial declined slightly to…
Hawkins reported quarterly sales of $255,879,000, up modestly from $251,120,000 a year ago, with substantial margin expansion driving operating income to $39,791,000 and diluted EPS to $1.38. All three segments posted…
Hawkins reported quarterly sales of $219.218M, up $32.168M (+17.2%) versus $187.050M a year earlier, with diluted EPS of $0.51 versus $0.48 prior year. Revenue growth was broad-based (Industrial and Water Treatment) but…
Hawkins reported strong top-line growth in Q1: revenue rose to $246.543M from $181.241M (+$65.302M) and diluted EPS increased to $0.94 from $0.79 (+$0.15). Margin mix shifted: gross margin declined to 19.0% from 21.5%…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.